检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

P-260: Daratumumab (DARA) plus bortezomib and dexamethasone (D-Vd) or lenalidomide and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): subgroup analyses of CASTOR and POLLUX

María-Victoria Mateos,Paul Richardson,Katja Weisel,Philippe Moreau,Jesus San-Miguel,Hartmut Goldschmidt,Robert Orlowski,Pieter Sonneveld,Donna E. Reece,Kenshi Suzuki,Nizar Bahlis,Sung-Soo Yoon,Andrew Spencer,Ajay Nooka,Vania Hungria,Torben Plesner,Dina Ben Yehuda,Huiling Pei,Wendy Garvin Mayo,Xue Gai,Jodi Carey,Robin Carson,Meletios A. Dimopoulos

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览1
暂无评分
关键词
refractory multiple myeloma,multiple myeloma,daratumumab,lenalidomide
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要